APA (7th ed.) Citation

L, L. A., HA, D., D, Y. G., B, G. N., & Z, N. M. (2021). Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia. Dove Medical Press.

Chicago Style (17th ed.) Citation

L, Lisanwork Arage, Deybasso HA, Yilma Gebremichael D, Gintamo Nuramo B, and Negash Mekuria Z. Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia. Dove Medical Press, 2021.

MLA (8th ed.) Citation

L, Lisanwork Arage, et al. Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia. Dove Medical Press, 2021.